Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair

Randomized Controlled Trial on Pre-operative Withdrawal Versus no Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair

This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery.

This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery. Simple randomization will be performed and allocation is via closed envelope method. The surgeon will be blinded regarding the usage of Aspirin. The primary outcome is the incidence of post-operative hematoma formation within the first 24 hours after surgery. The secondary outcomes are the incidence of post-operative seroma formation within 24 hours, the incidence of post-operative hematoma requiring intervention (including blood transfusion, percutaneous drainage and surgical hemostasis) within 30 days, pain at regular intervals and the incidence of other post-operative complications.

Inclusion Criteria:

• Patients with a diagnosis of inguinal hernia undergoing laparoscopic repair
• Age 21-80 years
• Patients taking Aspirin
• BMI 18-30

Exclusion Criteria:

• Age <21 and >80years
• Recurrent inguinal hernia
• Coagulopathy
• Patients who can't stop Aspirin
• BMI <18 and >30